Xinma Bio

About:

Xinma Bio engages in the development and production of biological products.

Website: http://www.novocodex.cn/

Top Investors: Runtu Touzi, SDIC Capital, Advanced Manufacturing Industry Investment Fund

Description:

Xinma Bio engages in the development and production of biological products. The company has expertise and capacities in genetic engineering development, cell culture, toxin synthesis, ADC coupling, preparation filling, preclinical research, and clinical research. Xinma Bio aims to continuously improve the level of research and development technology.

Total Funding Amount:

400M CNY

Headquarters Location:

Shaoxing, Zhejiang, China

Founded Date:

2016-01-01

Contact Email:

novocodex(AT)zmc.top

Founders:

Number of Employees:

101-250

Last Funding Date:

2022-07-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai